Zdrowie i gospodarka · 20/07/2015

FDA Requests Public Comment on Proposed Collection of Information for Market Claims in Direct-to-Consumer Prescription Drug Print Ads

The Food and Drug Administration (FDA) is seeking public input on a proposed collection of information related to market claims in direct-to-consumer prescription drug print ads, as required by the Paperwork Reduction Act of 1995.